Neuro-Oncology Reviews
Volume
28 Number 18
30 June 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 18, 30 June
Brizini M, Perreault S, Bennett J, Hassan H.
Advances
in the management of pediatric low-grade glioma.
Neurotherapeutics.
2026 Jun 24;23(6):e00952. doi:
10.1016/j.neurot.2026.e00952. PMID:
42341366. ˍ
Kim KM, Byeon Y, Lee C, Lee WJ, Hwang K, Dho YS, Sung KS, Roh TH,
Chong K, Park KS, Kang SH, Kim EH.
Targeting
IDH-Mutant Glioma with Vorasidenib : A New Era in Precision
Neuro-Oncology.
J
Korean Neurosurg Soc. 2026 Jun 24. doi:
10.3340/jkns.2026.0113. PMID:
42342239. ˍ
Lafont J, Kerhervé M, André N, Le Grand M, Pasquier
E.
Precision
neuro-oncology for children: Time to gear up!
Trends
Cancer. 2026 Jun 26:S2405-8033(26)00129-9. doi:
10.1016/j.trecan.2026.06.001. PMID:
42350191. ˍ
Zhang D, Zhang Y, Liu F, Zhang C, Jiang S.
Radiotherapy
resistance in glioblastoma: Mechanistic insights and novel
therapeutic approaches (Review).
Int
J Oncol. 2026 Jun 26;69(2):94. doi:
10.3892/ijo.2026.5907. PMID:
42359694. ˍ
Sabet K, Lovell H, Fonseca A.
Pediatric
medulloblastoma.
Childs
Nerv Syst. 2026 Jun 27;42(1):271. doi:
10.1007/s00381-026-07376-9. PMID:
42365163˰ ˍ
Lahariya R, Sinha M.
Overcoming
resistance in glioblastoma immunotherapy: lessons from the past
and opportunities for the future.
Mol
Biol Rep. 2026 Jun 30;53(1):1049. doi:
10.1007/s11033-026-12216-9. PMID:
42377714˰ ˍ
Piec K, Blok M, Adamczak-Sobczak M, Zarębska I, Harat M.
Cognitive
Impairment in Patients with Glioma: Mechanisms, Assessment, and
Emerging Therapeutic Strategies.
Cancers
(Basel). 2026 Jun 7;18(12):1865. doi:
10.3390/cancers18121865. PMID:
42352400. ˍ
Morcos A, Jung Y, Fuller RN, Jutzy JMS, Wall NR.
Extracellular
Vesicles in Diffuse Midline Glioma: Emerging Mediators of
Radiation Response and Therapeutic Resistance.
Cancers
(Basel). 2026 Jun 13;18(12):1933. doi:
10.3390/cancers18121933. PMID:
42352467. ˍ
Kang KD, Zhang Z, Bernstock JD, Friedman GK.
Oncolytic
viruses enhance CAR-T activity for the treatment of pediatric
diffuse midline gliomas.
Mol
Ther Oncol. 2026 Jun 16;34(3):201255. doi:
10.1016/j.omton.2026.201255. PMID:
42358379. ˍ
Mikołajczak K, Chmiel J, Leszek J.
Neuroinflammation
in Alzheimer's Disease (AD) and Glioblastoma (GBM): Shared
Mechanisms and Therapeutic Insights.
Cells.
2026 Jun 19;15(12):1111. doi:
10.3390/cells15121111. PMID:
42346137. ˍ
Tanzhu GL, Chen L, Ning JY, Xiao G, Wen S, Wang C, Wen H, Zhang
KQ, Yang J, Jia MY, Deng HB, Marti TM, Lockman PR, Zhou RR.
Crosstalk
in the brain tumor microenvironment: mechanisms, therapeutic
strategies, and clinical advances.
Mil
Med Res. 2026 Jun 20;13(1):100047. doi:
10.1016/j.mmr.2026.100047. PMID:
42375809. ˍ
Chan YB, Pang RKJ, Pang BC, Yeo TT, Tan BY.
Glioblastoma:
current challenges and future horizons.
Singapore
Med J. 2026 Jun 26;67(6):383-386. doi:
10.4103/singaporemedj.SMJ-2026-356. PMID:
42359712. ˍ